![HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection](http://hcv-trials.com/nash/Aramchol_Abs_LB5/big/Diapositive4.jpg)
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
![Frontiers | Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments | Pharmacology Frontiers | Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments | Pharmacology](https://www.frontiersin.org/files/Articles/603926/fphar-11-603926-HTML-r1/image_m/fphar-11-603926-g001.jpg)
Frontiers | Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments | Pharmacology
![IJERPH | Free Full-Text | Pharmacological Therapy of Non-Alcoholic Fatty Liver Disease: What Drugs Are Available Now and Future Perspectives | HTML IJERPH | Free Full-Text | Pharmacological Therapy of Non-Alcoholic Fatty Liver Disease: What Drugs Are Available Now and Future Perspectives | HTML](https://www.mdpi.com/ijerph/ijerph-16-04334/article_deploy/html/images/ijerph-16-04334-g001.png)
IJERPH | Free Full-Text | Pharmacological Therapy of Non-Alcoholic Fatty Liver Disease: What Drugs Are Available Now and Future Perspectives | HTML
![Aramchol downregulates stearoyl CoA-desaturase 1 in hepatic stellate cells to attenuate cellular fibrogenesis - JHEP Reports Aramchol downregulates stearoyl CoA-desaturase 1 in hepatic stellate cells to attenuate cellular fibrogenesis - JHEP Reports](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/fd901273-201f-4686-9a36-ca8df4a840bb/fx1_lrg.jpg)
Aramchol downregulates stearoyl CoA-desaturase 1 in hepatic stellate cells to attenuate cellular fibrogenesis - JHEP Reports
![HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection](http://hcv-trials.com/nash/Aramchol_Abs_LB5/big/Diapositive2.jpg)
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
![Galmed closes patient enrolment for Phase IIb ARREST study of Aramchol to treat liver diseases - Clinical Trials Arena Galmed closes patient enrolment for Phase IIb ARREST study of Aramchol to treat liver diseases - Clinical Trials Arena](https://www.drugdevelopment-technology.com/wp-content/uploads/image-digitalinsightresearch/Active/2016Q3/2.NRI/Drug%20development/News/Core%20News/January_2017/Galmed%20NASH%2010%20Jan.jpg)
Galmed closes patient enrolment for Phase IIb ARREST study of Aramchol to treat liver diseases - Clinical Trials Arena
![HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection](http://hcv-trials.com/nash/Aramchol_Abs_LB5/big/Diapositive1.jpg)
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
![FDA Agrees with Galmed's Plan to use Aramchol Meglumine in the Randomized Double-Blind Placebo-Controlled Part of the Phase 3 ARMOR study FDA Agrees with Galmed's Plan to use Aramchol Meglumine in the Randomized Double-Blind Placebo-Controlled Part of the Phase 3 ARMOR study](http://mma.prnewswire.com/media/595923/Galmed_Pharmaceuticals_Ltd_Logo.jpg?p=twitter)
FDA Agrees with Galmed's Plan to use Aramchol Meglumine in the Randomized Double-Blind Placebo-Controlled Part of the Phase 3 ARMOR study
![The Fatty Acid–Bile Acid Conjugate Aramchol Reduces Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease - Clinical Gastroenterology and Hepatology The Fatty Acid–Bile Acid Conjugate Aramchol Reduces Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease - Clinical Gastroenterology and Hepatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/9cd9ea41-6b34-48c7-8e3d-300df6aba7d1/gr1_lrg.jpg)
The Fatty Acid–Bile Acid Conjugate Aramchol Reduces Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease - Clinical Gastroenterology and Hepatology
![Drug discovery and treatment paradigms in nonalcoholic steatohepatitis - Noureddin - 2020 - Endocrinology, Diabetes & Metabolism - Wiley Online Library Drug discovery and treatment paradigms in nonalcoholic steatohepatitis - Noureddin - 2020 - Endocrinology, Diabetes & Metabolism - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/7746adfb-7b4b-4b48-ba9e-781a344795f7/edm2105-toc-0001-m.jpg)
Drug discovery and treatment paradigms in nonalcoholic steatohepatitis - Noureddin - 2020 - Endocrinology, Diabetes & Metabolism - Wiley Online Library
![HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection](http://hcv-trials.com/nash/Aramchol_Abs_LB5/Diapositive1.jpg)
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
![Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial | Nature Medicine Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial | Nature Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-021-01495-3/MediaObjects/41591_2021_1495_Fig1_HTML.png)
Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial | Nature Medicine
![One-year results of the Global Phase 2b randomized placebo-controlled ARREST Trial of Aramchol, a Stearoyl CoA Desaturasemodulator in NASH patients One-year results of the Global Phase 2b randomized placebo-controlled ARREST Trial of Aramchol, a Stearoyl CoA Desaturasemodulator in NASH patients](https://www.natap.org/2018/images%20/121218/121218-4/1212182.gif)
One-year results of the Global Phase 2b randomized placebo-controlled ARREST Trial of Aramchol, a Stearoyl CoA Desaturasemodulator in NASH patients
![HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection](http://hcv-trials.com/nash/Aramchol_Abs_LB5/big/Diapositive3.jpg)